NGS based RNA seq Market is set to reach $7,984.90 Million in 2027 with 19.3% of CAGR Led by Pacific Biosciences of California, Qaigen, F. Hoffmann-La Roche AG, Agilent Technologies, BGI, Oxford Nanopore Technologies
NGS based RNA seq is done without a reference sequence for the strand-specific libraries that are being profiled for the rare and novel therapeutics. It is highly revolutionized study of the transcriptome which is highly sensitive and accurate for the measurement of the expression all over the transcriptome. The NGs based RNA seq provides researchers with visibility for previously undetected changes occurring in disease states, in response to therapeutics caused by different environmental conditions. In addition, this technique enables researchers to detect the known and unknown features in single assay. The report would be of an interest to various stakeholders operating in the NGS based RNA seq market. These stakeholders include manufacturing companies, dealer companies, supplier companies, wholesalers, hospitals, research centers and others.
Get Sample Copy at https://www.theinsightpartners.com/sample/TIPBT00002556?sk
Major Players Operating in the NGS-based RNA-seq Market-
1. Illumina, Inc.
2. Thermo Fisher Scientific Inc.
3. Pacific Biosciences of California, Inc.
5. F. Hoffmann-La Roche AG
6. Agilent Technologies, Inc.
8. Oxford Nanopore Technologies
9. Perkinelmer, Inc.
10. Eurofins Scientific
According to a new market research study titled ‘NGS-Based RNA-Seq Market to 2027 – Global Analysis and Forecasts by Product & Services, Technology, Application and End User, the global NGS-based RNA-seq market was valued at US$ 1,240.87 Mn in 2017 and is estimated to reach US$ 7,984.90 Mn by 2027. The market is estimated to grow with a CAGR of 19.3% from 2018-2027.The report highlights the trends prevalent in the global NGS-based RNA-seq market and the factors driving the market along with those that act as deterrents to its growth.
Global NGS-based RNA-seq market is expected to grow in the coming years, owing to the factors such as, reduced cost of genome sequencing, advancements in sequencing technology and next generation sequencing for cancer. However, the risks related to genetic data and high cost of NGS instruments is act as a restraint for this market. On the other hand, barcode scanning for long reads sequences likely to add novel opportunities for NGS-based RNA-seq market, in the coming years.
Have Questions? Ask us at https://www.theinsightpartners.com/inquiry/TIPBT00002556?sk
The report segments the global NGS-based RNA-seq market as follows:
Global NGS-Based RNA-Seq Market – By Product & Services
• Sample Preparation
• Manual Method
• Automated Method
• Workflow Step
• Library Preparation & Target Enrichment
• Fragmentation, End Repair & Size Selection
• Quality Control
• Sequencing Services
• Sequencing Platform & Consumables
• Data Analysis, Storage & Management
Global NGS-Based RNA-Seq Market – By Technology
• Sequencing By Synthesis
• Nanopore Sequencing
• Ion Semiconductor Sequencing
• Single-Molecule Real-Time (SMRT) Sequencing
Global NGS-Based RNA-Seq Market – By Application
• Drug Discovery
• Precision Medicine
Global NGS-Based RNA-Seq Market – By End User
• Hospitals & Clinics
• Research Centers and Academic & Government Institutes
• Biotechnology & Pharmaceutical Companies
Global NGS-Based RNA-Seq Market – By Geography
• North America
• Asia Pacific (APAC)
• Middle East & Africa (MEA)
• Saudi Arabia
• South Africa
• South and Central America (SCAM)
Buy this Report now at https://www.theinsightpartners.com/buy/TIPBT00002556?sk
Contact us –
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : email@example.com
About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release NGS based RNA seq Market is set to reach $7,984.90 Million in 2027 with 19.3% of CAGR Led by Pacific Biosciences of California, Qaigen, F. Hoffmann-La Roche AG, Agilent Technologies, BGI, Oxford Nanopore Technologies here
News-ID: 1770439 • Views: 1034
More Releases from The Insight Partners
Chatbot Market trend shows a rapid growth by 2027- Nuance Communications, Artifi …
Chatbot is a type of artificial intelligence systems which interacts with the users through speech, text, and messaging. With the increasing demand and usage of messaging applications made easy accessibility of customized bot and therefore strengthen the growth of Chatbot market. There are many Chatbot platform present like WeChat, Facebook messenger, WhatsApp among others, all these chatbots has become the necessity for many industries. The increasing demand of computerized patient
Mixed Reality in Gaming Market 2019-2027 Study includes Top Key Players as Micro …
Mixed Reality (MR) in Gaming is a technology combining real environment and virtual world which increases efficiency by reducing time in product designing. MR is also termed as hybrid reality, it produces new surrounding and visualizations where physical and digital objects stands and interacts in real time. As demand for smartphone, tablet is increasing, it is offering a large scope to MR also. More to it, for giving proper and
Event Stream Processing Market to 2027 - Google, IBM, Informatica, Microsoft, Or …
The analysis of the global Event Stream Processing Market 2027 is an in-depth study of the Event Stream Processing industry, which focuses on global market trends. The report aims to provide an overview of the global market for Event Stream Processing with detailed market segmentation by product / application and by region. The global market for Event Stream Processing is expected to experience strong Growth over the forecast period. The reports
System of Insight Market to 2027 - GoodData, IBM, INETCO Systems, Medallia, NGDA …
The analysis of the global System of Insight Market 2027 is an in-depth study of the System of Insight industry, which focuses on global market trends. The report aims to provide an overview of the global market for System of Insight with detailed market segmentation by product / application and by region. The global market for System of Insight is expected to experience strong Growth over the forecast period. The reports
More Releases for NGS
NGS Data Analysis Market to Undertake Strapping Growth During 2026
With continuous developments in cloud computing and data integration solutions, bottlenecks in data handling are being effectively addressed, which includes high throughput sequence data’s sizeable volume analysis. Introduction of NGS solutions coupled with rising clinical diagnosis requirement for personalized treatment of several ailments and genomic research, have created demand for precise and fasts sequencing and algorithms interpretation tools that can analyze data faster. This Fact.MR report analyzes the expansion of
NGS Data Analysis Market to Observe Strong Development by 2026
With continuous developments in cloud computing and data integration solutions, bottlenecks in data handling are being effectively addressed, which includes high throughput sequence data’s sizeable volume analysis. Introduction of NGS solutions coupled with rising clinical diagnosis requirement for personalized treatment of several ailments and genomic research, have created demand for precise and fasts sequencing and algorithms interpretation tools that can analyze data faster. Report overview @ https://www.xploremr.com/report/679/ngs-data-analysis-market This Fact.MR report analyzes
Next-generation Sequencing (NGS) Market Unbeaten over 2025
Next-generation Sequencing (NGS) Market: Snapshot Next Generation Sequencing (NGS) is utilized to execute different applications, for instance, biomarker revelation, oncology thinks about, customized solution, rural and creature research, and others. NGS has streamlined nucleotide investigation and has broadly supplanted customary instruments of genomics, particularly microarray effectively. The interest for NGS has expanded altogether inferable from surge in NGS applications and ascend in mechanical progressions in NGS. What's more, the development in
Next Generation Sequencing (NGS) Data Analysis Market Trepidation In 2025
Next Generation Sequencing (NGS) Data Analysis Market: Snapshot NGS is the term which is used to describe a number of different modern sequencing technologies and is also known as high throughput sequencing. Researchers are allowed to examine the biological systems, deeply due to exceptional throughput, scalability of systems, and speed by the next generation sequencing (NGS). In present times, a greater level of understanding is demanded due to the complexities involved
Global Next Generation Sequencing (NGS) Market Is driven by Increased in adoptio …
The Global Next-Generation Sequencing (NGS) Market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Global Next-Generation Sequencing (NGS) Market for
Next Generation Sequencing (NGS) at a CAGR of 23.59%
The Asia-Pacific NGS market which was worth $ 567.7 million in 2016 is poised to reach $1,636.7 million by 2021 at a CAGR of 23.59%. Asia presents significant opportunities for the investors/venture capitalists as the developed markets are saturated. The presence of noteworthy developments by China and Japan for integration of new technologies and the development of healthcare is majorly driving the Asia Pacific Market. Sample Report Request: https://www.reportsandmarkets.com/sample-request/1214607-12/2016 R&D and